Metformin News and Research

RSS
Metformin is the active ingredient in a drug used to treat diabetes mellitus (a condition in which the body cannot control the level of sugar in the blood). It is also being studied in the treatment of cancer. It decreases the amount of glucose (a type of sugar) released into the bloodstream from the liver and increases the body’s use of the glucose. Metformin is a type of antidiabetic agent.
Study offers renewed hope for children suffering from myofibrillar myopathies

Study offers renewed hope for children suffering from myofibrillar myopathies

University of Minnesota receives funding to initiate research on diabetes drug as a COVID-19 treatment

University of Minnesota receives funding to initiate research on diabetes drug as a COVID-19 treatment

Researchers identify biomarkers that predict patient’s response to metformin treatment

Researchers identify biomarkers that predict patient’s response to metformin treatment

Combined use of three drugs linked with lower lung cancer incidence and mortality

Combined use of three drugs linked with lower lung cancer incidence and mortality

NTU-incubated start-up plans clinical trial of new slow-release pill for Parkinson’s disease

NTU-incubated start-up plans clinical trial of new slow-release pill for Parkinson’s disease

Common diabetes drug controls aspects of inflammation in mice

Common diabetes drug controls aspects of inflammation in mice

Study shows fatty liver disease is a significant risk factor for COVID-19 hospitalization

Study shows fatty liver disease is a significant risk factor for COVID-19 hospitalization

Study identifies important regulator of neuron function and survival

Study identifies important regulator of neuron function and survival

Novel drug candidate offers a major advance in the treatment for diabetes

Novel drug candidate offers a major advance in the treatment for diabetes

Immunotherapy does not worsen complications for patients with both COVID-19 and cancer

Immunotherapy does not worsen complications for patients with both COVID-19 and cancer

People with accelerated biological age at increased risk of COVID-19 symptom severity and mortality

People with accelerated biological age at increased risk of COVID-19 symptom severity and mortality

Apotex recalls some Metformin batches due to possible carcinogen

Apotex recalls some Metformin batches due to possible carcinogen

Oral antidiabetics improve outcomes in diabetics with colorectal cancer

Oral antidiabetics improve outcomes in diabetics with colorectal cancer

AMPK activation by anti-diabetes drug promotes survival of dormant breast cancer cells

AMPK activation by anti-diabetes drug promotes survival of dormant breast cancer cells

Newer therapies may benefit patients with type 2 diabetes and coronary artery disease

Newer therapies may benefit patients with type 2 diabetes and coronary artery disease

People with type 2 diabetes and heart disease may benefit from newer therapies

People with type 2 diabetes and heart disease may benefit from newer therapies

Scientist proposes geroprotective strategies to reduce lethality of COVID-19 in the elderly

Scientist proposes geroprotective strategies to reduce lethality of COVID-19 in the elderly

Molecule found in oranges could reduce obesity and reverse its negative side-effects

Molecule found in oranges could reduce obesity and reverse its negative side-effects

Glucose-lowering drug reduces obesity indices in children and adolescents, study shows

Glucose-lowering drug reduces obesity indices in children and adolescents, study shows

Acid reflux drug may be a promising therapy to reduce preterm birth

Acid reflux drug may be a promising therapy to reduce preterm birth